Differential induction of activation markers in macrophage cell lines by interferon-gamma.
Macrophage cell lines were used in these studies as a model system to dissect the biochemical and functional mosaic of the macrophage activation process. In particular, the requirements for the induction of tumoricidal and bactericidal activity in the RAW 264.7 and WEHI-3 cell lines by interferon-gamma (IFN-gamma) and bacterial lipopolysaccharide (LPS) were determined. Changes in expression of a series of macrophage markers traditionally associated with macrophage activation were monitored during stimulation of the cells in order to determine whether a detectable pattern of activation-associated changes is associated with the development of a particular functional activity. These markers included changes in the cell surface expression of major histocompatibility complex-encoded Class I and Class II antigens and antigens in the Mac-1/LFA-1 family, alterations in the levels of membrane enzymes (5' nucleotidase and alkaline phosphodiesterase), and production of secretory products including hydrogen peroxide and the monokines interleukin-1, interferons-alpha/beta, and tumor necrosis factor-alpha. Our results demonstrate that a given homogeneous macrophage population expresses a distinct subset of functional activities in response to single, defined activating signals such as IFN-gamma and LPS. The display of a variety of macrophage surface antigens, enzymes, and secreted products is activated simultaneously by such treatment; however, the particular pattern of such activation-associated markers cannot reproducibly be used to predict the ability of an activated cell to perform a particular function. The results also suggest that macrophage cell lines expressing differential response patterns following IFN-gamma stimulation provide a valuable system for dissection of the molecular and cell biology of macrophage activation.
Lambert
L E
LE
Department of Medical Microbiology, University of Wisconsin Medical School, Madison 53706.
Paulnock
D M
DM
D015720:5'-Nucleotidase; D000818:Animals; D000954:Antigens, Surface / Q000032:analysis; D001685:Biological Factors / Q000096:biosynthesis; D002460:Cell Line; D016207:Cytokines; D003602:Cytotoxicity, Immunologic; D006861:Hydrogen Peroxide / Q000378:metabolism; D007371:Interferon-gamma / Q000494:pharmacology*; D008070:Lipopolysaccharides / Q000494:pharmacology; D008214:Lymphocytes / Q000276:immunology; D008262:Macrophage Activation / Q000187:drug effects*; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D009708:Nucleotidases / Q000032:analysis; D043264:Phosphodiesterase I; D010727:Phosphoric Diester Hydrolases / Q000032:analysis
D000954:Antigens, Surface; D001685:Biological Factors; D016207:Cytokines; D008070:Lipopolysaccharides; D007371:Interferon-gamma; D006861:Hydrogen Peroxide; D009708:Nucleotidases; D015720:5'-Nucleotidase; D010727:Phosphoric Diester Hydrolases; D043264:Phosphodiesterase I